Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

Apr 25, 2020

30561_dirs_2020-04-24_dc82ea88-9ba7-410a-ae54-b00886859a5d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-04-23

Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-23 Common Stock G 80799 Disposed 85985 Direct
2020-04-23 Common Stock G 80799 Acquired 507121 Indirect
2020-04-23 Common Stock M 250000 $5.51 Acquired 335985 Direct
2020-04-23 Common Stock F 156360 $26.37 Disposed 179625 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-23 Option (right to buy) $5.51 M 250000 Disposed 2020-09-17 Common Stock (250000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 17728 Indirect

Footnotes

F1: On April 23, 2020, the Reporting Person gifted 80,799 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended

F2: Includes 85,985 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.

F3: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

F4: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 93,640 shares of Common Stock on the net exercise of a stock option to purchase 250,000 shares of Common Stock. The Issuer withheld 156,360 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on April 23, 2020 of $26.37.

F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of April 22, 2020.

F6: The option, representing the right to purchase a total of 720,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017.